Autor: "Bodar YJL" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Determining the diagnostic value of PSMA-PET/CT imaging in patients with persistent high prostate specific antigen levels and negative prostate biopsies.
Autorzy:: Bodar, YJL (AUTHOR) y.j.bodar@amsterdamumc.nl
Koene, BPF (AUTHOR)
Meijer, D (AUTHOR)
van Leeuwen, PJ (AUTHOR)
Nadorp, S (AUTHOR)
Donswijk, ML (AUTHOR)
Hendrikse, NH (AUTHOR)
Oprea-Lager, DE (AUTHOR)
Vis, AN (AUTHOR)
van Leeuwen, P J (AUTHOR)
Donswijk, M L (AUTHOR)
Hendrikse, N H (AUTHOR)
Oprea-Lager, D E (AUTHOR)
Vis, A N (AUTHOR); Pokaż więcej
Źródło:: Urologic Oncology. Feb2022, Vol. 40 Issue 2, p58.e1-58.e7. 1p.

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 2.

Tytuł:: Higher Preoperative Maximum Standardised Uptake Values (SUV max ) Are Associated with Higher Biochemical Recurrence Rates after Robot-Assisted Radical Prostatectomy for [ F]DCFPyL Positron Emission Tomography/Computed Tomography.
Autorzy:: de Bie KCC; Department of Urology, VU University, Amsterdam University Medical Centers, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.; Department of Radiology & Nuclear Medicine, VU University, Amsterdam University Medical Centers, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.; Prostate Cancer Network The Netherlands, 1066 CX Amsterdam, The Netherlands.
Veerman H; Department of Urology, VU University, Amsterdam University Medical Centers, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.; Prostate Cancer Network The Netherlands, 1066 CX Amsterdam, The Netherlands.; Department of Urology, Antoni van Leeuwenhoek Hospital-The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands.
Bodar YJL; Department of Urology, VU University, Amsterdam University Medical Centers, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.; Department of Radiology & Nuclear Medicine, VU University, Amsterdam University Medical Centers, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.; Prostate Cancer Network The Netherlands, 1066 CX Amsterdam, The Netherlands.
Meijer D; Department of Urology, VU University, Amsterdam University Medical Centers, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.; Department of Radiology & Nuclear Medicine, VU University, Amsterdam University Medical Centers, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.; Prostate Cancer Network The Netherlands, 1066 CX Amsterdam, The Netherlands.
van Leeuwen PJ; Prostate Cancer Network The Netherlands, 1066 CX Amsterdam, The Netherlands.; Department of Urology, Antoni van Leeuwenhoek Hospital-The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands.
van der Poel HG; Prostate Cancer Network The Netherlands, 1066 CX Amsterdam, The Netherlands.; Department of Urology, Antoni van Leeuwenhoek Hospital-The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands.
Donswijk ML; Department of Radiology and Nuclear Medicine, Antoni van Leeuwenhoek Hospital-The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands.
Vis AN; Department of Urology, VU University, Amsterdam University Medical Centers, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.; Prostate Cancer Network The Netherlands, 1066 CX Amsterdam, The Netherlands.
Oprea-Lager DE; Department of Radiology & Nuclear Medicine, VU University, Amsterdam University Medical Centers, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.; Pokaż więcej
Źródło:: Diagnostics (Basel, Switzerland) [Diagnostics (Basel)] 2023 Jul 11; Vol. 13 (14). Date of Electronic Publication: 2023 Jul 11.
Typ publikacji:: Journal Article

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: The oncological characteristics of non-prostate-specific membrane antigen (PSMA)-expressing primary prostate cancer on preoperative PSMA positron emission tomography/computed tomography.
Autorzy:: Veerman H; Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.; Department of Urology, Amsterdam University Medical Centres, Location VU Medical Centre, Amsterdam, the Netherlands.; Prostate Cancer Network Netherlands, Amsterdam, the Netherlands.
Donswijk M; Department of Nuclear Medicine, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
Bekers E; Department of Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
Bodar YJL; Department of Urology, Amsterdam University Medical Centres, Location VU Medical Centre, Amsterdam, the Netherlands.; Prostate Cancer Network Netherlands, Amsterdam, the Netherlands.
Meijer D; Department of Urology, Amsterdam University Medical Centres, Location VU Medical Centre, Amsterdam, the Netherlands.; Prostate Cancer Network Netherlands, Amsterdam, the Netherlands.
van Moorselaar RJA; Department of Urology, Amsterdam University Medical Centres, Location VU Medical Centre, Amsterdam, the Netherlands.; Prostate Cancer Network Netherlands, Amsterdam, the Netherlands.
Oprea-Lager DE; Department of Radiology and Nuclear Medicine, Cancer Center Amsterdam, Amsterdam University Medical Centres, Location VU Medical Centre, Amsterdam, the Netherlands.
van der Noort V; Department of Biometrics, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
van Leeuwen PJ; Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.; Prostate Cancer Network Netherlands, Amsterdam, the Netherlands.
Vis AN; Department of Urology, Amsterdam University Medical Centres, Location VU Medical Centre, Amsterdam, the Netherlands.; Prostate Cancer Network Netherlands, Amsterdam, the Netherlands.
van der Poel HG; Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.; Department of Urology, Amsterdam University Medical Centres, Location VU Medical Centre, Amsterdam, the Netherlands.; Prostate Cancer Network Netherlands, Amsterdam, the Netherlands.; Pokaż więcej
Źródło:: BJU international [BJU Int] 2022 Dec; Vol. 130 (6), pp. 750-753. Date of Electronic Publication: 2022 Sep 30.
Typ publikacji:: Journal Article
MeSH Terms:: Positron Emission Tomography Computed Tomography*/methods
Prostatic Neoplasms*/diagnostic imaging
Prostatic Neoplasms*/surgery
Male ; Humans ; Gallium Radioisotopes ; Prostatectomy/methods ; Prostate-Specific Antigen ; Retrospective Studies

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Standardised uptake values as determined on prostate-specific membrane antigen positron emission tomography/computed tomography is associated with oncological outcomes in patients with prostate cancer.
Autorzy:: Bodar YJL; Department of Urology, Amsterdam University Medical Center, VU University, Amsterdam, the Netherlands.; Department of Radiology & Nuclear Medicine, Amsterdam University Medical Center, VU University, Amsterdam, the Netherlands.; Prostate Cancer Network The Netherlands, Amsterdam, the Netherlands.
Veerman H; Department of Urology, Amsterdam University Medical Center, VU University, Amsterdam, the Netherlands.; Prostate Cancer Network The Netherlands, Amsterdam, the Netherlands.; Department of Urology, Prostate Cancer Network The Netherlands, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
Meijer D; Department of Urology, Amsterdam University Medical Center, VU University, Amsterdam, the Netherlands.; Department of Radiology & Nuclear Medicine, Amsterdam University Medical Center, VU University, Amsterdam, the Netherlands.; Prostate Cancer Network The Netherlands, Amsterdam, the Netherlands.
de Bie K; Department of Urology, Amsterdam University Medical Center, VU University, Amsterdam, the Netherlands.
van Leeuwen PJ; Prostate Cancer Network The Netherlands, Amsterdam, the Netherlands.; Department of Urology, Prostate Cancer Network The Netherlands, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
Donswijk ML; Department of Radiology and Nuclear Medicine, Prostate Cancer Network The Netherlands, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
van Moorselaar RJA; Department of Urology, Amsterdam University Medical Center, VU University, Amsterdam, the Netherlands.; Prostate Cancer Network The Netherlands, Amsterdam, the Netherlands.
Hendrikse NH; Department of Radiology & Nuclear Medicine, Amsterdam University Medical Center, VU University, Amsterdam, the Netherlands.
Boellaard R; Department of Radiology & Nuclear Medicine, Amsterdam University Medical Center, VU University, Amsterdam, the Netherlands.
Oprea-Lager DE; Department of Radiology & Nuclear Medicine, Amsterdam University Medical Center, VU University, Amsterdam, the Netherlands.
Vis AN; Department of Urology, Amsterdam University Medical Center, VU University, Amsterdam, the Netherlands.; Prostate Cancer Network The Netherlands, Amsterdam, the Netherlands.; Pokaż więcej
Źródło:: BJU international [BJU Int] 2022 Jun; Vol. 129 (6), pp. 768-776. Date of Electronic Publication: 2022 Mar 12.
Typ publikacji:: Journal Article
MeSH Terms:: Positron Emission Tomography Computed Tomography*/methods
Prostatic Neoplasms*/diagnostic imaging
Prostatic Neoplasms*/pathology
Prostatic Neoplasms*/surgery
Gallium Isotopes ; Gallium Radioisotopes ; Humans ; Male ; Prospective Studies ; Prostate/diagnostic imaging ; Prostate/pathology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Prospective analysis of clinically significant prostate cancer detection with [ F]DCFPyL PET/MRI compared to multiparametric MRI: a comparison with the histopathology in the radical prostatectomy specimen, the ProStaPET study.
Autorzy:: Bodar YJL; Department of Urology, Amsterdam University Medical Centres (VU University Medical Center), Amsterdam, the Netherlands. y.j.bodar@amsterdamumc.nl.; Department of Radiology & Nuclear Medicine, Amsterdam University Medical Centres (VU University Medical Center), Amsterdam, the Netherlands. y.j.bodar@amsterdamumc.nl.; Prostate Cancer Network, Amsterdam, the Netherlands. y.j.bodar@amsterdamumc.nl.
Zwezerijnen BGJC; Department of Radiology & Nuclear Medicine, Amsterdam University Medical Centres (VU University Medical Center), Amsterdam, the Netherlands.
van der Voorn PJ; Department of Pathology, Amsterdam University Medical Centres (VU University Medical Center), Amsterdam, the Netherlands.
Jansen BHE; Department of Urology, Amsterdam University Medical Centres (VU University Medical Center), Amsterdam, the Netherlands.; Department of Radiology & Nuclear Medicine, Amsterdam University Medical Centres (VU University Medical Center), Amsterdam, the Netherlands.; Prostate Cancer Network, Amsterdam, the Netherlands.
Smit RS; Department of Radiology & Nuclear Medicine, Amsterdam University Medical Centres (VU University Medical Center), Amsterdam, the Netherlands.
Kol SQ; Department of Radiology & Nuclear Medicine, Amsterdam University Medical Centres (VU University Medical Center), Amsterdam, the Netherlands.
Meijer D; Department of Urology, Amsterdam University Medical Centres (VU University Medical Center), Amsterdam, the Netherlands.; Department of Radiology & Nuclear Medicine, Amsterdam University Medical Centres (VU University Medical Center), Amsterdam, the Netherlands.; Prostate Cancer Network, Amsterdam, the Netherlands.
de Bie K; Department of Urology, Amsterdam University Medical Centres (VU University Medical Center), Amsterdam, the Netherlands.
Yaqub M; Department of Radiology & Nuclear Medicine, Amsterdam University Medical Centres (VU University Medical Center), Amsterdam, the Netherlands.
Windhorst BAD; Department of Radiology & Nuclear Medicine, Amsterdam University Medical Centres (VU University Medical Center), Amsterdam, the Netherlands.; Department of Clinical Pharmacology and Pharmacy, Amsterdam University Medical Centres (VU University Medical Center), Amsterdam, the Netherlands.
Hendrikse HNH; Department of Radiology & Nuclear Medicine, Amsterdam University Medical Centres (VU University Medical Center), Amsterdam, the Netherlands.; Department of Clinical Pharmacology and Pharmacy, Amsterdam University Medical Centres (VU University Medical Center), Amsterdam, the Netherlands.
Vis AN; Department of Urology, Amsterdam University Medical Centres (VU University Medical Center), Amsterdam, the Netherlands.; Prostate Cancer Network, Amsterdam, the Netherlands.
Oprea-Lager DE; Department of Radiology & Nuclear Medicine, Amsterdam University Medical Centres (VU University Medical Center), Amsterdam, the Netherlands.; Pokaż więcej
Źródło:: European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2022 Apr; Vol. 49 (5), pp. 1731-1742. Date of Electronic Publication: 2021 Nov 02.
Typ publikacji:: Journal Article
MeSH Terms:: Multiparametric Magnetic Resonance Imaging*
Prostatic Neoplasms*/diagnostic imaging
Prostatic Neoplasms*/surgery
Humans ; Image-Guided Biopsy ; Magnetic Resonance Imaging/methods ; Male ; Positron-Emission Tomography ; Prostate/pathology ; Prostatectomy ; Tomography, X-Ray Computed

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: The clinical characteristics of patients with primary non-prostate-specific membrane antigen-expressing prostate cancer on preoperative positron emission tomography/computed tomography.
Autorzy:: Veerman H; Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Department of Urology, Location VU Medical Centre, Amsterdam University Medical Centres, Amsterdam, The Netherlands.; Prostate Cancer Network Netherlands, Amsterdam, The Netherlands.
Donswijk M; Department of Nuclear Medicine, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
Bekers E; Department of Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
Olde Heuvel J; Department of Nuclear Medicine, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
Bodar YJL; Department of Urology, Location VU Medical Centre, Amsterdam University Medical Centres, Amsterdam, The Netherlands.; Prostate Cancer Network Netherlands, Amsterdam, The Netherlands.
Boellaard TN; Department of Radiology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
van Montfoort ML; Department of Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
van Moorselaar RJA; Department of Urology, Location VU Medical Centre, Amsterdam University Medical Centres, Amsterdam, The Netherlands.; Prostate Cancer Network Netherlands, Amsterdam, The Netherlands.
Oprea-Lager DE; Department of Radiology and Nuclear Medicine, Cancer Center Amsterdam, Location VU Medical Centre, Amsterdam University Medical Centres, Amsterdam, The Netherlands.
van Leeuwen PJ; Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Prostate Cancer Network Netherlands, Amsterdam, The Netherlands.
Vis AN; Department of Urology, Location VU Medical Centre, Amsterdam University Medical Centres, Amsterdam, The Netherlands.; Prostate Cancer Network Netherlands, Amsterdam, The Netherlands.
van der Poel HG; Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Department of Urology, Location VU Medical Centre, Amsterdam University Medical Centres, Amsterdam, The Netherlands.; Prostate Cancer Network Netherlands, Amsterdam, The Netherlands.; Pokaż więcej
Źródło:: BJU international [BJU Int] 2022 Mar; Vol. 129 (3), pp. 314-317. Date of Electronic Publication: 2021 Dec 13.
Typ publikacji:: Journal Article
MeSH Terms:: Positron Emission Tomography Computed Tomography*/methods
Prostatic Neoplasms*/diagnostic imaging
Prostatic Neoplasms*/surgery
Gallium Radioisotopes ; Humans ; Male ; Prostate-Specific Antigen

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Management impact of F-DCFPyL PET/CT in hormone-sensitive prostate cancer patients with biochemical recurrence after definitive treatment: a multicenter retrospective study.
Autorzy:: Meijer D; Department of Urology, Prostate Cancer Network the Netherlands, Amsterdam University Medical Center, VU University, De Boelelaan 1117, 1081, Amsterdam, HV, The Netherlands. .; Department of Radiology and Nuclear Medicine, Cancer Center Amsterdam, Amsterdam University Medical Center, VU University, Amsterdam, The Netherlands. .
van Leeuwen PJ; Department of Urology, Prostate Cancer Network the Netherlands, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Oosterholt PMJ; Department of Urology, Prostate Cancer Network the Netherlands, Amsterdam University Medical Center, VU University, De Boelelaan 1117, 1081, Amsterdam, HV, The Netherlands.
Bodar YJL; Department of Urology, Prostate Cancer Network the Netherlands, Amsterdam University Medical Center, VU University, De Boelelaan 1117, 1081, Amsterdam, HV, The Netherlands.; Department of Radiology and Nuclear Medicine, Cancer Center Amsterdam, Amsterdam University Medical Center, VU University, Amsterdam, The Netherlands.
van der Poel HG; Department of Urology, Prostate Cancer Network the Netherlands, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Hendrikse NH; Department of Radiology and Nuclear Medicine, Cancer Center Amsterdam, Amsterdam University Medical Center, VU University, Amsterdam, The Netherlands.; Department of Clinical Pharmacology and Pharmacy, Amsterdam University Medical Center, VU University, Amsterdam, The Netherlands.
Donswijk ML; Department of Urology, Prostate Cancer Network the Netherlands, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Wondergem M; Department of Nuclear Medicine, Noordwest Ziekenhuisgroep, Alkmaar, The Netherlands.
Vellekoop AE; Department of Urology, Amstelland Hospital, Amstelveen, The Netherlands.
van Moorselaar RJA; Department of Urology, Prostate Cancer Network the Netherlands, Amsterdam University Medical Center, VU University, De Boelelaan 1117, 1081, Amsterdam, HV, The Netherlands.
Nieuwenhuijzen JA; Department of Urology, Prostate Cancer Network the Netherlands, Amsterdam University Medical Center, VU University, De Boelelaan 1117, 1081, Amsterdam, HV, The Netherlands.; Department of Urology, Prostate Cancer Network the Netherlands, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Oprea-Lager DE; Department of Radiology and Nuclear Medicine, Cancer Center Amsterdam, Amsterdam University Medical Center, VU University, Amsterdam, The Netherlands.
Vis AN; Department of Urology, Prostate Cancer Network the Netherlands, Amsterdam University Medical Center, VU University, De Boelelaan 1117, 1081, Amsterdam, HV, The Netherlands.; Department of Urology, Prostate Cancer Network the Netherlands, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Pokaż więcej
Źródło:: European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2021 Aug; Vol. 48 (9), pp. 2960-2969. Date of Electronic Publication: 2021 Feb 05.
Typ publikacji:: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms:: Positron Emission Tomography Computed Tomography*
Prostatic Neoplasms*/diagnostic imaging
Prostatic Neoplasms*/therapy
Hormones ; Humans ; Lysine ; Male ; Retrospective Studies ; Urea

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Cylindroma, an uncommon presentation on F-DCFPyL PET/CT.
Autorzy:: Koene BPF; Department of Urology, Amsterdam University Medical Centers (VU University), Amsterdam, The Netherlands. .
Bodar YJL; Department of Urology, Amsterdam University Medical Centers (VU University), Amsterdam, The Netherlands.; Department of Radiology & Nuclear Medicine, Amsterdam University Medical Centers (VU University), Amsterdam, The Netherlands.; Prostate Cancer Network, Amsterdam, The Netherlands.
Meijer D; Department of Urology, Amsterdam University Medical Centers (VU University), Amsterdam, The Netherlands.; Department of Radiology & Nuclear Medicine, Amsterdam University Medical Centers (VU University), Amsterdam, The Netherlands.; Prostate Cancer Network, Amsterdam, The Netherlands.
Jaspars EH; Department of Pathology, Amsterdam University Medical Centers, Amsterdam, The Netherlands.
Vis AN; Department of Urology, Amsterdam University Medical Centers (VU University), Amsterdam, The Netherlands.; Prostate Cancer Network, Amsterdam, The Netherlands.
Oprea-Lager DE; Department of Radiology & Nuclear Medicine, Amsterdam University Medical Centers (VU University), Amsterdam, The Netherlands.; Pokaż więcej
Źródło:: European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2021 Mar; Vol. 48 (3), pp. 927-928. Date of Electronic Publication: 2020 Jul 11.
Typ publikacji:: Case Reports; Journal Article
MeSH Terms:: Carcinoma, Adenoid Cystic*/diagnostic imaging
Prostatic Neoplasms*
Humans ; Male ; Positron Emission Tomography Computed Tomography ; Radiopharmaceuticals ; Urea

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Pelvic lymph-node staging with F-DCFPyL PET/CT prior to extended pelvic lymph-node dissection in primary prostate cancer - the SALT trial.
Autorzy:: Jansen BHE; Department of Urology, Amsterdam University Medical Centres (VU University), De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands. .; Department of Radiology & Nuclear medicine, Amsterdam University Medical Centres (VU University), De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands. .; Prostate Cancer Network, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands. .
Bodar YJL; Department of Urology, Amsterdam University Medical Centres (VU University), De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands. y.j.bodar@amsterdamumc.nl.; Department of Radiology & Nuclear medicine, Amsterdam University Medical Centres (VU University), De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands. y.j.bodar@amsterdamumc.nl.; Prostate Cancer Network, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands. y.j.bodar@amsterdamumc.nl.
Zwezerijnen GJC; Department of Radiology & Nuclear medicine, Amsterdam University Medical Centres (VU University), De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.
Meijer D; Department of Urology, Amsterdam University Medical Centres (VU University), De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.; Department of Radiology & Nuclear medicine, Amsterdam University Medical Centres (VU University), De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.; Prostate Cancer Network, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.
van der Voorn JP; Department of Pathology, Amsterdam University Medical Centres (VU University), Amsterdam, The Netherlands.
Nieuwenhuijzen JA; Department of Urology, Amsterdam University Medical Centres (VU University), De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.; Prostate Cancer Network, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.
Wondergem M; Department of Nuclear medicine, Noordwest Ziekenhuisgroep, Alkmaar, The Netherlands.
Roeleveld TA; Prostate Cancer Network, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.; Department of Urology, Noordwest Ziekenhuisgroep, Alkmaar, The Netherlands.
Boellaard R; Department of Radiology & Nuclear medicine, Amsterdam University Medical Centres (VU University), De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.
Hoekstra OS; Department of Radiology & Nuclear medicine, Amsterdam University Medical Centres (VU University), De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.
van Moorselaar RJA; Department of Urology, Amsterdam University Medical Centres (VU University), De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.; Prostate Cancer Network, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.
Oprea-Lager DE; Department of Radiology & Nuclear medicine, Amsterdam University Medical Centres (VU University), De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.
Vis AN; Department of Urology, Amsterdam University Medical Centres (VU University), De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.; Prostate Cancer Network, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.; Pokaż więcej
Źródło:: European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2021 Feb; Vol. 48 (2), pp. 509-520. Date of Electronic Publication: 2020 Aug 12.
Typ publikacji:: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms:: Positron Emission Tomography Computed Tomography*
Prostatic Neoplasms*/diagnostic imaging
Prostatic Neoplasms*/pathology
Cohort Studies ; Dissection ; Humans ; Male ; Neoplasm Staging ; Prospective Studies

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: Clinical verification of 18F-DCFPyL PET-detected lesions in patients with biochemically recurrent prostate cancer.
Autorzy:: Meijer D; Department of Urology, Prostate Cancer Network Amsterdam, Amsterdam University Medical Centers, VU University, Amsterdam, The Netherlands.; Department of Radiology & Nuclear Medicine, Cancer Center Amsterdam, Amsterdam University Medical Centers, VU University, Amsterdam, The Netherlands.
Jansen BHE; Department of Urology, Prostate Cancer Network Amsterdam, Amsterdam University Medical Centers, VU University, Amsterdam, The Netherlands.; Department of Radiology & Nuclear Medicine, Cancer Center Amsterdam, Amsterdam University Medical Centers, VU University, Amsterdam, The Netherlands.
Wondergem M; Department of Nuclear Medicine, Noordwest Ziekenhuisgroep, Alkmaar, The Netherlands.
Bodar YJL; Department of Urology, Prostate Cancer Network Amsterdam, Amsterdam University Medical Centers, VU University, Amsterdam, The Netherlands.; Department of Radiology & Nuclear Medicine, Cancer Center Amsterdam, Amsterdam University Medical Centers, VU University, Amsterdam, The Netherlands.
Srbljin S; Department of Nuclear Medicine, Zaans Medical Center, Zaandam, The Netherlands.
Vellekoop AE; Department of Urology, Amstelland Hospital, Amstelveen, The Netherlands.
Keizer B; Department of Urology, Dijklander Hospital, Hoorn, The Netherlands.
van der Zant FM; Department of Nuclear Medicine, Noordwest Ziekenhuisgroep, Alkmaar, The Netherlands.
Hoekstra OS; Department of Radiology & Nuclear Medicine, Cancer Center Amsterdam, Amsterdam University Medical Centers, VU University, Amsterdam, The Netherlands.
Nieuwenhuijzen JA; Department of Urology, Prostate Cancer Network Amsterdam, Amsterdam University Medical Centers, VU University, Amsterdam, The Netherlands.
Dahele M; Department of Radiation Oncology, Cancer Center Amsterdam, Amsterdam, The Netherlands.
Vis AN; Department of Urology, Prostate Cancer Network Amsterdam, Amsterdam University Medical Centers, VU University, Amsterdam, The Netherlands.
Oprea-Lager DE; Department of Radiology & Nuclear Medicine, Cancer Center Amsterdam, Amsterdam University Medical Centers, VU University, Amsterdam, The Netherlands.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2020 Oct 06; Vol. 15 (10), pp. e0239414. Date of Electronic Publication: 2020 Oct 06 (Print Publication: 2020).
Typ publikacji:: Journal Article
MeSH Terms:: Positron Emission Tomography Computed Tomography*
Lysine/*analogs & derivatives
Prostatic Neoplasms/*diagnostic imaging
Prostatic Neoplasms/*metabolism
Urea/*analogs & derivatives
Aged ; Humans ; Image Processing, Computer-Assisted ; Male ; Middle Aged ; Retrospective Studies

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Bodar YJL"" wg kryterium: Autor

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język